Cargando…
Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation
Colorectal cancer (CRC) is the fifth leading cause of cancer death and the fifth most commonly diagnosed cancer in China. Approximately, 25% of CRC was in the advanced stage as diagnosed, and 40% of patients with CRC progress to metastatic colorectal cancer (mCRC). RAS mutation status is now routine...
Autores principales: | Liu, Ruiqi, Peng, Ke, Yu, Yiyi, Liang, Li, Xu, Xiaojing, Li, Wei, Yu, Shan, Liu, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831827/ https://www.ncbi.nlm.nih.gov/pubmed/29662888 http://dx.doi.org/10.1155/2018/5920608 |
Ejemplares similares
-
Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer
por: Xu, Xiaojing, et al.
Publicado: (2023) -
FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc
por: Yu, Yiyi, et al.
Publicado: (2016) -
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020) -
Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019) -
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023)